1. Home
  2. VRAX vs WAFU Comparison

VRAX vs WAFU Comparison

Compare VRAX & WAFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • WAFU
  • Stock Information
  • Founded
  • VRAX 2013
  • WAFU 1999
  • Country
  • VRAX United Kingdom
  • WAFU China
  • Employees
  • VRAX N/A
  • WAFU N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • WAFU Other Consumer Services
  • Sector
  • VRAX Health Care
  • WAFU Real Estate
  • Exchange
  • VRAX Nasdaq
  • WAFU Nasdaq
  • Market Cap
  • VRAX 7.3M
  • WAFU 7.1M
  • IPO Year
  • VRAX 2022
  • WAFU 2019
  • Fundamental
  • Price
  • VRAX $1.90
  • WAFU $1.76
  • Analyst Decision
  • VRAX
  • WAFU
  • Analyst Count
  • VRAX 0
  • WAFU 0
  • Target Price
  • VRAX N/A
  • WAFU N/A
  • AVG Volume (30 Days)
  • VRAX 282.7K
  • WAFU 42.5K
  • Earning Date
  • VRAX 02-05-2025
  • WAFU 01-01-0001
  • Dividend Yield
  • VRAX N/A
  • WAFU N/A
  • EPS Growth
  • VRAX N/A
  • WAFU N/A
  • EPS
  • VRAX N/A
  • WAFU N/A
  • Revenue
  • VRAX $84,872.00
  • WAFU $7,223,220.00
  • Revenue This Year
  • VRAX $5,169.18
  • WAFU N/A
  • Revenue Next Year
  • VRAX $66.97
  • WAFU N/A
  • P/E Ratio
  • VRAX N/A
  • WAFU N/A
  • Revenue Growth
  • VRAX 7.03
  • WAFU N/A
  • 52 Week Low
  • VRAX $0.60
  • WAFU $1.46
  • 52 Week High
  • VRAX $9.00
  • WAFU $2.63
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 49.13
  • WAFU 51.05
  • Support Level
  • VRAX $1.58
  • WAFU $1.63
  • Resistance Level
  • VRAX $2.10
  • WAFU $1.83
  • Average True Range (ATR)
  • VRAX 0.25
  • WAFU 0.13
  • MACD
  • VRAX 0.01
  • WAFU -0.01
  • Stochastic Oscillator
  • VRAX 47.88
  • WAFU 43.33

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About WAFU Wah Fu Education Group Limited

Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services, and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.

Share on Social Networks: